Hamilton Lane (HLNE) to Release Earnings on Thursday

Hamilton Lane (NASDAQ:HLNE - Get Free Report) is anticipated to release its Q4 2025 earnings data before the market opens on Thursday, May 29th. Analysts expect Hamilton Lane to post earnings of $1.12 per share and revenue of $165.49 million for the quarter.

Hamilton Lane Stock Performance

NASDAQ HLNE opened at $161.72 on Thursday. The company has a market capitalization of $8.97 billion, a price-to-earnings ratio of 29.84 and a beta of 1.31. Hamilton Lane has a twelve month low of $114.85 and a twelve month high of $203.72. The stock has a fifty day simple moving average of $150.85 and a 200 day simple moving average of $159.63. The company has a quick ratio of 4.19, a current ratio of 4.19 and a debt-to-equity ratio of 0.34.

Hamilton Lane Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Investors of record on Friday, March 14th were issued a $0.49 dividend. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.96 dividend on an annualized basis and a yield of 1.21%. Hamilton Lane's payout ratio is 36.16%.

Hedge Funds Weigh In On Hamilton Lane

Hedge funds have recently modified their holdings of the company. Royal Bank of Canada lifted its position in shares of Hamilton Lane by 6.0% during the 1st quarter. Royal Bank of Canada now owns 52,466 shares of the company's stock worth $7,800,000 after buying an additional 2,948 shares in the last quarter. Jones Financial Companies Lllp lifted its position in shares of Hamilton Lane by 4,806.7% during the 1st quarter. Jones Financial Companies Lllp now owns 5,103 shares of the company's stock worth $759,000 after buying an additional 4,999 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in shares of Hamilton Lane by 196.9% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company's stock worth $57,000 after buying an additional 254 shares in the last quarter. Institutional investors own 97.40% of the company's stock.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Morgan Stanley reduced their target price on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a research note on Monday, April 14th. Wells Fargo & Company reduced their target price on Hamilton Lane from $152.00 to $147.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 8th. JPMorgan Chase & Co. reduced their target price on Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Keefe, Bruyette & Woods raised their target price on Hamilton Lane from $158.00 to $168.00 and gave the company a "market perform" rating in a research note on Wednesday, February 5th. Finally, Oppenheimer downgraded Hamilton Lane from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 15th. One research analyst has rated the stock with a sell rating and six have given a hold rating to the company's stock. According to MarketBeat, Hamilton Lane presently has an average rating of "Hold" and an average target price of $164.14.

About Hamilton Lane

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.